Medical research

NICE guidelines presented for management of thyroid disease

In a summary of a recent guideline from the National Institute for Health and Care Excellence (NICE), published online Jan. 29 in The BMJ, recommendations are presented for the assessment and management of thyroid disease.

Medications

Breakthrough alpha-ray treatment of cancer without external radiation

For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%. However, some thyroid tumors become resistant to iodine treatment ("iodine-refractory"), ...

Oncology & Cancer

Nexavar approval expanded for common thyroid cancer

(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.

page 1 from 2